ArticleJournal of experimental & clinical cancer research : CR2022

Targeting ZFP64/GAL-1 axis promotes therapeutic effect of nab-paclitaxel and reverses immunosuppressive microenvironment in gastric cancer.

Mengxuan Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.